Vivozon Pharmaceutical

082800 · KOSDAQ · Health Care · SMALL CAP

Rights offering: final issue price set (rights offering with public offering of forfeited shares)

Capital raise(Rights offering: final issue price set (rights offering with public offering of forfeited shares))· FILED 2026-02-19· RCEPT 20260219900450

About this filing

Sets or confirms the issue price of new shares in a rights or public offering, which is calculated from the recent share price under a formula fixed at the time of the decision.

Why companies file it: The issue price is fixed in stages and each stage is disclosed.

A full English translation of this filing is not available yet. The original (in Korean) is linked below.

Filed2026-02-19, Rights offering: final issue price set (rights offering with public offering of forfeited shares)
SourceDART rcept 20260219900450 → open original filing

Source: DART. Information only, not investment advice.

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-02-19 (KST). · Converted at 1 USD ≈ ₩1,325 (rate of 2026-10-21).